149 related articles for article (PubMed ID: 3872599)
1. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
Ratech H; Hirschhorn R; Thorbecke GJ
Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599
[TBL] [Abstract][Full Text] [Related]
2. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
3. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
4. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
[TBL] [Abstract][Full Text] [Related]
5. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
[TBL] [Abstract][Full Text] [Related]
6. Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Luebke RW; Lawson LD; Rogers RR; Riddle MM; Rowe DG; Smialowicz RJ
Immunopharmacology; 1987 Feb; 13(1):25-35. PubMed ID: 2952620
[TBL] [Abstract][Full Text] [Related]
7. Morphologic changes and immunohistochemical localization of adenosine deaminase in tissues of rats given injections of 2'-deoxycoformycin.
Checkik BE; Perets A; SenGupta S; Fernandes B
J Natl Cancer Inst; 1983 Nov; 71(5):999-1010. PubMed ID: 6358608
[TBL] [Abstract][Full Text] [Related]
8. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Barton RW
Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression by 2' deoxycoformycin: studies on the mode of administration.
Sordillo EM; Ikehara S; Good RA; Trotta PP
Cell Immunol; 1981 Sep; 63(2):259-71. PubMed ID: 6974052
[No Abstract] [Full Text] [Related]
10. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
Smith CM; Henderson JF
Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
[TBL] [Abstract][Full Text] [Related]
11. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
Helland S; Ueland PM
Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
[TBL] [Abstract][Full Text] [Related]
12. Immune function in mice exposed to the adenosine deaminase inhibitor 2'-deoxycoformycin during immune system development.
Luebke RW; Lawson LD; Rogers RR; Riddle MM; Smialowicz RJ
Immunopharmacol Immunotoxicol; 1987; 9(2-3):149-61. PubMed ID: 3501794
[TBL] [Abstract][Full Text] [Related]
13. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
14. Effect of ADA deficiency on cultured murine thymus transplantation.
Hong R; Horowitz SD; Fortman C; Martin DW
Clin Immunol Immunopathol; 1982 May; 23(2):448-58. PubMed ID: 6980759
[No Abstract] [Full Text] [Related]
15. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
16. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Agarwal RP
Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
[No Abstract] [Full Text] [Related]
17. Studies of the relationship between adenosine deaminase and immune function.
Burridge PW; Paetkau V; Henderson JF
J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
[TBL] [Abstract][Full Text] [Related]
18. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
Earle MF; Glazer RI
Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
[No Abstract] [Full Text] [Related]
19. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
[TBL] [Abstract][Full Text] [Related]
20. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
Thuillier L; Garreau F; Cartier PH
Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
